Barclays’s Stericycle Inc SRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,400
Closed -$68K 6373
2020
Q1
$68K Sell
1,400
-2,900
-67% -$171K ﹤0.01% 5032
2019
Q4
$274K Buy
4,300
+2,800
+187% +$166K ﹤0.01% 4789
2019
Q3
$76K Sell
1,500
-2,800
-65% -$130K ﹤0.01% 5682
2019
Q2
$205K Sell
4,300
-9,600
-69% -$488K ﹤0.01% 5079
2019
Q1
$756K Buy
13,900
+6,000
+76% +$272K ﹤0.01% 3711
2018
Q4
$290K Sell
7,900
-8,500
-52% -$399K ﹤0.01% 4309
2018
Q3
$962K Sell
16,400
-3,900
-19% -$249K ﹤0.01% 3664
2018
Q2
$1.32M Buy
20,300
+3,800
+23% +$236K ﹤0.01% 2972
2018
Q1
$966K Buy
16,500
+12,000
+267% +$812K ﹤0.01% 3257
2017
Q4
$306K Sell
4,500
-7,100
-61% -$482K ﹤0.01% 4328
2017
Q3
$831K Buy
11,600
+5,000
+76% +$368K ﹤0.01% 3173
2017
Q2
$504K Sell
6,600
-200
-3% -$16.4K ﹤0.01% 3520
2017
Q1
$564K Sell
6,800
-291,700
-98% -$23.4M ﹤0.01% 3284
2016
Q4
$23M Sell
298,500
-5,500
-2% -$415K 0.02% 537
2016
Q3
$24.4M Buy
304,000
+303,300
+43,329% +$27.4M 0.03% 464
2016
Q2
$73K Sell
700
-1,100
-61% -$118K ﹤0.01% 4620
2016
Q1
$227K Buy
1,800
+600
+50% +$69.9K ﹤0.01% 3754
2015
Q4
$144K Sell
1,200
-3,900
-76% -$497K ﹤0.01% 4154
2015
Q3
$709K Buy
5,100
+3,800
+292% +$529K ﹤0.01% 3043
2015
Q2
$173K Sell
1,300
-1,100
-46% -$151K ﹤0.01% 4240
2015
Q1
$336K Sell
2,400
-1,700
-41% -$230K ﹤0.01% 3947
2014
Q4
$537K Sell
4,100
-300
-7% -$37.8K ﹤0.01% 3805
2014
Q3
$510K Buy
4,400
+200
+5% +$23.6K ﹤0.01% 3935
2014
Q2
$496K Sell
4,200
-4,600
-52% -$526K ﹤0.01% 3986
2014
Q1
$995K Buy
8,800
+5,600
+175% +$647K ﹤0.01% 3241
2013
Q4
$371K Sell
3,200
-5,300
-62% -$618K ﹤0.01% 4388
2013
Q3
$978K Buy
8,500
+5,400
+174% +$623K ﹤0.01% 3374
2013
Q2
$342K Buy
+3,100
New +$337K ﹤0.01% 4656

Other funds holding SRCL

Barclays's SRCL Position: Q4 2024 in Review

Barclays sold out of Stericycle Inc (SRCL) in Q4 2024, closing a stake of 1,595,177 shares — an estimated $97.3M sold.

Barclays first reported a position in SRCL in Q2 2013 and held it in 46 quarters. The position peaked at $97.3M in Q3 2024. 4 funds tracked by Wall St. Rank hold SRCL as of Q4 2024.

  • Barclays reported no remaining Stericycle Inc position as of Q4 2024 after selling out during the quarter.
  • Barclays sold 1,595,177 Stericycle Inc shares in Q4 2024, an estimated $97.3M.
  • Barclays first reported a position in Stericycle Inc in Q2 2013 and held it in 46 quarters.
  • Barclays's Stericycle Inc position peaked at $97.3M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2024.

Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.